From phenotypic screening to target and compound prioritization for autosomal dominant polycystic kidney disease.
- DOI
- 10.1016/j.slasd.2026.100338
- Published
- 2026 Sep 15
- Container
- SLAS discovery : advancing life sciences R & D
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.slasd.2026.100338,
title = {From phenotypic screening to target and compound prioritization for autosomal dominant polycystic kidney disease.},
author = {Araripe DA and Iljin M and Bange H and Price LS and Liu R and van der Es D and Heitman LH and Peters DJM and van Westen GJP},
year = {2026},
journal = {SLAS discovery : advancing life sciences R \& D},
doi = {10.1016/j.slasd.2026.100338},
url = {https://doi.org/10.1016/j.slasd.2026.100338}
}RIS
TY - JOUR TI - From phenotypic screening to target and compound prioritization for autosomal dominant polycystic kidney disease. AU - Araripe DA AU - Iljin M AU - Bange H AU - Price LS AU - Liu R AU - van der Es D AU - Heitman LH AU - Peters DJM AU - van Westen GJP PY - 2026 JO - SLAS discovery : advancing life sciences R & D DO - 10.1016/j.slasd.2026.100338 UR - https://doi.org/10.1016/j.slasd.2026.100338 ER -
APA
DA, A., M, I., H, B., LS, P., R, L., D, V. D. E., LH, H., DJM, P., & GJP, V. W. (2026). From phenotypic screening to target and compound prioritization for autosomal dominant polycystic kidney disease.. SLAS discovery : advancing life sciences R & D. https://doi.org/10.1016/j.slasd.2026.100338
Source records
- pubmed · retrieved 2026-09-26T17:57:50.001Z